Interestingly, the percentage of patients presenting with high Skp2 levels in locally advance disease was similar to that of patients presenting with high Skp2 levels in early breast cancer (40% and 42%, respectively) [36]. This evidence concerns the gene SKP2 and breast carcinoma.